Adding delayed recall to the Alzheimer Disease Assessment Scale is useful in studies of mild cognitive impairment but not Alzheimer disease.

Adding delayed recall to the Alzheimer Disease Assessment Scale is useful in studies of mild cognitive impairment but not Alzheimer disease.

Item
http://www.wikidata.org/entity/Q36478298
Alzheimer's Disease Neuroimaging Initiative 2 Clinical Core: Progress and plansThe Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI.The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.Functional neural correlates of attentional deficits in amnestic mild cognitive impairment.Executive and attentional functions in chronic pain: does performance decrease with increasing task load?Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative.Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementiaStructural brain alterations before mild cognitive impairment in ADNI: validation of volume loss in a predefined antero-temporal region.Outcomes Assessment in Clinical Trials of Alzheimer's Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs.Optimizing Effect Sizes With Imaging Enrichment and Outcome Choices for Mild Alzheimer Disease Clinical Trials.Correlation of thiamine metabolite levels with cognitive function in the non-demented elderly.ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease.The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review.Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)
P2860

Adding delayed recall to the Alzheimer Disease Assessment Scale is useful in studies of mild cognitive impairment but not Alzheimer disease.

Item
http://www.wikidata.org/entity/Q36478298
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Adding delayed recall to the A ...... ent but not Alzheimer disease.
@ast
Adding delayed recall to the A ...... ent but not Alzheimer disease.
@en
type
label
Adding delayed recall to the A ...... ent but not Alzheimer disease.
@ast
Adding delayed recall to the A ...... ent but not Alzheimer disease.
@en
prefLabel
Adding delayed recall to the A ...... ent but not Alzheimer disease.
@ast
Adding delayed recall to the A ...... ent but not Alzheimer disease.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Adding delayed recall to the A ...... ent but not Alzheimer disease.
@en
P2093
P2860
P304
P31
P356
10.1097/WAD.0B013E3181F883B7
P407
P433
P478
P50
P577
P698
P921
P932